IT202200007229A1 - Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche - Google Patents
Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche Download PDFInfo
- Publication number
- IT202200007229A1 IT202200007229A1 IT102022000007229A IT202200007229A IT202200007229A1 IT 202200007229 A1 IT202200007229 A1 IT 202200007229A1 IT 102022000007229 A IT102022000007229 A IT 102022000007229A IT 202200007229 A IT202200007229 A IT 202200007229A IT 202200007229 A1 IT202200007229 A1 IT 202200007229A1
- Authority
- IT
- Italy
- Prior art keywords
- acetylcysteine
- vitamin
- composition including
- nutraceutical compositions
- related pharmaceutical
- Prior art date
Links
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title 2
- 239000000203 mixture Substances 0.000 title 2
- 108010024636 Glutathione Proteins 0.000 title 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 title 1
- 229960004308 acetylcysteine Drugs 0.000 title 1
- 229960003180 glutathione Drugs 0.000 title 1
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000007229A IT202200007229A1 (it) | 2022-04-12 | 2022-04-12 | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche |
PCT/IB2023/053745 WO2023199244A1 (en) | 2022-04-12 | 2023-04-12 | Composition comprising n-acetylcysteine, vitamin d and preferably glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000007229A IT202200007229A1 (it) | 2022-04-12 | 2022-04-12 | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202200007229A1 true IT202200007229A1 (it) | 2023-10-12 |
Family
ID=82385403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102022000007229A IT202200007229A1 (it) | 2022-04-12 | 2022-04-12 | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202200007229A1 (it) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998029101A1 (en) * | 1996-12-31 | 1998-07-09 | Antioxidant Pharmaceuticals Corporation | Pharmaceutical preparations of glutathione and methods of administration thereof |
WO2003077900A1 (en) * | 2002-03-14 | 2003-09-25 | Prevention, L.L.C. | A unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
US20070116779A1 (en) * | 2005-11-23 | 2007-05-24 | Elizabeth Mazzio | Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease |
JP2010120916A (ja) * | 2008-11-22 | 2010-06-03 | Rena Science:Kk | 体内生理活性モノアミンの減少に関連して発症する精神・神経疾患の改善または治療剤 |
US10105419B2 (en) * | 2015-02-13 | 2018-10-23 | Eastern Vision Limited | Dietary supplements and formulations |
WO2020053754A1 (en) | 2018-09-10 | 2020-03-19 | Uriach Italia S.R.L. | Composition comprising lipoic acid and vitamin d for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies |
US20200254073A1 (en) * | 2017-10-27 | 2020-08-13 | Beyond Barriers Therapeutics, Inc. | Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress |
-
2022
- 2022-04-12 IT IT102022000007229A patent/IT202200007229A1/it unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998029101A1 (en) * | 1996-12-31 | 1998-07-09 | Antioxidant Pharmaceuticals Corporation | Pharmaceutical preparations of glutathione and methods of administration thereof |
WO2003077900A1 (en) * | 2002-03-14 | 2003-09-25 | Prevention, L.L.C. | A unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
US20070116779A1 (en) * | 2005-11-23 | 2007-05-24 | Elizabeth Mazzio | Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease |
JP2010120916A (ja) * | 2008-11-22 | 2010-06-03 | Rena Science:Kk | 体内生理活性モノアミンの減少に関連して発症する精神・神経疾患の改善または治療剤 |
US10105419B2 (en) * | 2015-02-13 | 2018-10-23 | Eastern Vision Limited | Dietary supplements and formulations |
US20200254073A1 (en) * | 2017-10-27 | 2020-08-13 | Beyond Barriers Therapeutics, Inc. | Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress |
WO2020053754A1 (en) | 2018-09-10 | 2020-03-19 | Uriach Italia S.R.L. | Composition comprising lipoic acid and vitamin d for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies |
Non-Patent Citations (5)
Title |
---|
ALI AMMAR ET AL: "Vitamin D exerts neuroprotection via SIRT1/nrf-2/ NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice", NEUROCHEMISTRY INTERNATIONAL, ELSEVIER, AMSTERDAM, NL, vol. 142, 4 November 2020 (2020-11-04), XP086431488, ISSN: 0197-0186, [retrieved on 20201104], DOI: 10.1016/J.NEUINT.2020.104893 * |
FRANCESCA UBERTI ET AL: "Protective effects of 1 ? ,25-Dihydroxyvitamin D3 on cultured neural cells exposed to catalytic iron", PHYSIOLOGICAL REPORTS, vol. 4, no. 11, 1 June 2016 (2016-06-01), US, pages e12769, XP055586068, ISSN: 2051-817X, DOI: 10.14814/phy2.12769 * |
LEMON J A ET AL: "A dietary supplement abolishe age-related cognitive defcline in transgenic mice expressing elevated free radical processes", EXPERIMENTAL BIOLOGY AND MEDICINE, SAGE PUBLICATIONS LTD, GB, vol. 228, 1 January 2003 (2003-01-01), pages 800 - 810, XP002436865, ISSN: 1535-3702 * |
MOLINARI CMORSANUTO VGHIRLANDA S ET AL.: "Role of combined Lipoic acid and Vitamin D3 on Astrobytes as a way to prevent Brain aging by induced oxidative stress and Iron accumulation", OXID MED CELI LONGEV, 28 February 2019 (2019-02-28) |
ROSS ERIKA K ET AL: "Immunocal and preservation of glutathione as a novel neuroprotective strategy for degenerative disorders of the nervous system", RECENT PATENTS ON CNS DRUG DISCOVERY, BENTHAM SCIENCE PUBLISHERS LTD, NL, vol. 7, no. 3, 30 November 2012 (2012-11-30), pages 230 - 235, XP009501358, ISSN: 2212-3954 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017001847A1 (es) | Una formulación sólida de dosificación farmacéutica | |
NO20081878L (no) | Diacylindazolderivater som lipase- og fosfolipaseinhibitorer | |
ES2556585T3 (es) | Composiciones que comprenden sulfato de salbutamol | |
BRPI0608402B8 (pt) | compostos de flavonóide e composições compreendendo os mesmos | |
AR065246A1 (es) | Composiciones para mejorar la absorcion gastrointestinal de nutrientes y de farmacos | |
UY30215A1 (es) | Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones | |
BR112012006692A2 (pt) | composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas | |
BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
AR051397A1 (es) | Composicion farmaceutica | |
AR060387A1 (es) | Suplementos alimenticios y sus usos | |
CR10505A (es) | Aminopirazolopiridinas sustituidas y sus sales, sus preparaciones y composiciones farmaceuticas que las comprenden | |
BRPI0617294B8 (pt) | composição farmacêutica em gel hidroalcóolico e uso de testosterona | |
ATE511514T1 (de) | Phosphadiazin-hcv-polymerase-hemmer vom typ iv | |
WO2007036802A3 (en) | Sublingual dosage form comrising vitamin d analogue, in particular calcitriol | |
BR112016010875A8 (pt) | Composição útil para a promoção da fertilidade feminina | |
GT200800107A (es) | Formulaciones orales que comprenden tigeciclina | |
BRPI0814189A2 (pt) | Ácido ribonucleico de filamento duplo, composição farmacêutica e seus usos, método para inibir a expressão de fosfatidilinositol 4-cinase, vetor e uso de um composto que seletivamente inibe a atividade da fosfatidilinositol 4-cinase. | |
NO20054945L (no) | Orale formulering av cladribin | |
ECSP10010167A (es) | Composiciones oftálmicas novedosas | |
DK3519416T3 (da) | Chroman, isochroman og dihydroisobenzofuranderivater som mglur2-negative allosteriske modulatorer, sammensætninger og anvendelse deraf | |
NO20092763L (no) | Isosorbid mononitrat derivater for behandling av tarmlidelser | |
IT202200007229A1 (it) | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche | |
IT202200007238A1 (it) | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche | |
IT202200007226A1 (it) | Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche | |
IT202200007232A1 (it) | Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche |